Jane H. YoonJane H.Yoon
Partner, Life Sciences & Healthcare
Jane H. Yoon is a partner in the Litigation practice of Paul Hastings and is based in the firm’s New York office. Ms. Yoon represents corporate entities and their executives in connection with government and internal investigations into allegations of potential violations of the federal anti-kickback statute, health care fraud, the Food Drug & Cosmetic Act, HIPAA and the False Claims Act. These matters range from conduct surrounding patient support/assistance programs, specialty pharmacy arrangements, clinical trials and investigator-initiated studies, promotional communications, and the full range of interactions between manufacturers, prescribers, third-party vendors, patients, and payers. Ms. Yoon also handles matters relating to allegations of billing fraud and Medicare risk adjustment practices under Medicare Advantage.
Represented an opioid manufacturer in connection with a multi-district federal investigation and a qui tam complaint focusing on promotional practices and alleging potential violations of the anti-kickback statute and False Claims Act, resulting in a $7.55 million civil-only settlement in the District of New Jersey.
Represented a company in connection with response to subpoenas from U.S. Attorney’s Offices and various federal agencies including HHS-OIG regarding claims for reimbursement of opioids and opioid use disorder treatments.
- Dispute Resolution - Corporate Investigations and White-Collar Criminal Defense: Advice to Corporates
Legal 500
- Healthcare: Life Sciences
Legal 500
On the Heels of Significant FCPA Settlements, Past and Present Meet as Novartis Reaches FCA Settlements in Two Districts, Paul Hastings, Co-Author
JULY 16, 2020
As Enforcement Against Hoarding and Price Gouging Escalates Amidst the COVID-19 Crisis, What Corporate Compliance Can Do, Paul Hastings, Co-Author
APRIL 28, 2020
Compliance in the Era of COVID-19 – Where and How Life Sciences and Health Care Companies Should Focus in the Era of Social Distancing, Paul Hastings, Co-Author
APRIL 22, 2020
Another Life Sciences Company Announces a Multi-Million Dollar Settlement in the U.S. Department of Justice’s Relentless Pursuit of Donations to Copay Assistance Charities, Law360.com, Author with Gary F. Giampetruzzi and Jessica R. Montes
JUNE 19, 2018
Against the Backdrop of a ‘National Emergency,’ Are Opioid Manufacturers Ready for the Enforcement Spotlight?, Bloomberg Law, Pharmaceutical Law Industry Report, Author with Gary F. Giampetruzzi and Sandra Gonzalez
AUGUST 25, 2017
Law Clerk
Hon. Joseph A. Greenaway, Jr., Third Circuit Court of Appeals (United States District Court, District of New Jersey)
- CBI’s Virtual Patient Support Services Congress Panel: “What to Watch: 2020 Compliance & Legal Trends,” PresenterOCTOBER 27, 2020
- CBI Specialty Pharmaceuticals Compliance Congress, “The Future of Biotech (CCO Discussion)” PresenterSeptember 2020